Mehta, Rutika

Publications

Sort by

Co-Author Network

selected publications

ASO Visual Abstract: Clinical and Pathologic Response to Neoadjuvant Immunotherapy in DNA Mismatch Repair Protein-Deficient Gastroesophageal Cancers. Annals of surgical oncology. 2024 Academic Article GET IT
Clinical and Pathologic Response to Neoadjuvant Immunotherapy in DNA Mismatch Repair Protein-Deficient Gastroesophageal Cancers. Annals of surgical oncology. 2024 Academic Article GET IT
Times cited: 1
Intra-operative pyloric BOTOX injection versus pyloric surgery for prevention of delayed gastric emptying after esophagectomy. Surgical endoscopy. 2024 Academic Article GET IT
Circulating tumor DNA molecular analyses and real-world evidence outcomes of FGFR2 amplified gastroesophageal cancers. The oncologist. 2024 Academic Article GET IT
Totally minimally invasive laparoscopic robot-assisted Ivor Lewis esophagectomy: improved technique and outcomes over 200 cases. Journal of gastrointestinal oncology. 2024 Academic Article GET IT
Initial Experience Using Laparoscopic HIPEC for Gastric Cancer with Peritoneal Metastasis: Safety and Outcomes. Annals of surgical oncology. 2024 Academic Article GET IT
Times cited: 3
Biomarker Analysis from a Phase I/Ib Study of Regorafenib and Nivolumab in Mismatch Repair-Proficient Advanced Refractory Colorectal Cancer. Cancers. 2024 Academic Article GET IT
RNA Expression-Based Analysis to Predict Response in Patients with Metastatic Mismatch Repair Proficient Colorectal Cancer Treated with Regorafenib and Nivolumab. Oncology. 2023 Academic Article GET IT
Locally advanced mismatch repair-deficient gastroesophageal junction cancer: Diagnosis, treatment modifications, and monitoring. CA: a cancer journal for clinicians. 2023 Academic Article GET IT
Induction Fluorouracil-Based Chemotherapy and PET-Adapted Consolidation Chemoradiation with Esophagectomy for High-Risk Gastroesophageal Adenocarcinoma. Cancers. 2023 Academic Article GET IT
Tumor Regression Grade and Overall Survival following Gastrectomy with Preoperative Therapy for Gastric Cancer. Annals of surgical oncology. 2023 Academic Article GET IT
Times cited: 8
Real-World Molecular Biomarker Testing Patterns and Results for Advanced Gastroesophageal Cancers in the United States. Current oncology (Toronto, Ont.). 2023 Academic Article GET IT
Times cited: 2
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2023 Academic Article GET IT
Phase I Study of Lenvatinib and Capecitabine with External Radiation Therapy in Locally Advanced Rectal Adenocarcinoma. The oncologist. 2022 Academic Article GET IT
Times cited: 1
The effect of histologic grade on neoadjuvant treatment outcomes in esophageal cancer. Journal of surgical oncology. 2022 Academic Article GET IT
A phase I/Ib study of regorafenib and nivolumab in mismatch repair proficient advanced refractory colorectal cancer. European journal of cancer. 2022 Academic Article GET IT
Times cited: 41
Evaluation of Tumor DNA Sequencing Results in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma Stratified by TP53 Mutation Status. The oncologist. 2022 Academic Article GET IT
Times cited: 4
Impact of histology classification on pathologic treatment response and overall survival in distal esophageal cancer patients: a propensity matched analysis. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus. 2021 Academic Article GET IT
Times cited: 2
A phase 1/2 trial of ibrutinib in combination with pembrolizumab in patients with mismatch repair proficient metastatic colorectal cancer. British journal of cancer. 2021 Academic Article GET IT
Times cited: 22
Phase 2 study of copanlisib in combination with gemcitabine and cisplatin in advanced biliary tract cancers. Cancer. 2020 Academic Article GET IT
Times cited: 23
Pretreatment CT and ¹⁸ F-FDG PET-based radiomic model predicting pathological complete response and loco-regional control following neoadjuvant chemoradiation in oesophageal cancer. Journal of medical imaging and radiation oncology. 2020 Academic Article GET IT
Times cited: 22
Outcomes of 350 Robotic-assisted Esophagectomies at a High-volume Cancer Center: A Contemporary Propensity-score Matched Analysis. Annals of surgery. 2020 Academic Article GET IT
Times cited: 19
Outcomes of Gastric Resection in the Establishment of a Comprehensive Oncologic Robotic Program. The Journal of surgical research. 2020 Academic Article GET IT
Times cited: 1
Clinical Factors and Outcomes of Octogenarians Receiving Curative Surgery for Esophageal Cancer. The Journal of surgical research. 2020 Academic Article GET IT
Times cited: 11
Clinical factors associated with the development of postoperative atrial fibrillation in esophageal cancer patients receiving multimodality therapy before surgery. Journal of gastrointestinal oncology. 2020 Academic Article GET IT
Times cited: 9
Prioritization of Therapy Options for a Patient With High Tumor Mutation Burden and Microsatellite Instability but No Clinical Benefit From Immunotherapy. 2019 GET IT
Times cited: 1
Is Preoperative G-Tube Use Safe for Esophageal Cancer Patients?. Journal of the American College of Nutrition. 2019 Academic Article GET IT
Times cited: 4
Patterns of Long-term Cancer Survivorship Care in a National Cancer Institute-Designated Comprehensive Cancer Center. American journal of clinical oncology. 2017 Academic Article GET IT
Times cited: 3
Cerebral fat embolism syndrome mimicking thrombotic thrombocytopenic purpura in a patient with hemoglobin SC disease. American journal of hematology. 2016 Conference Paper GET IT
Times cited: 16
Cancer Survivorship and Models of Survivorship Care: A Review. American journal of clinical oncology. 2015 Review GET IT
Times cited: 38
Gene Expression Analysis Reveals Distinct Pathways of Resistance to Bevacizumab in Xenograft Models of Human ER-Positive Breast Cancer. Journal of Cancer. 2014 Academic Article GET IT
Times cited: 9
Thrombophilia testing in children: a 7 year experience. Pediatric blood & cancer. 2013 Academic Article GET IT
Times cited: 8
Investigational drug MLN0128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft models. Breast cancer research and treatment. 2012 Academic Article GET IT
Times cited: 74
PHLDA1 is a crucial negative regulator and effector of Aurora A kinase in breast cancer. Journal of cell science. 2011 Academic Article GET IT
Times cited: 61
Atypical ductal hyperplasia: interobserver and intraobserver variability. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2011 Academic Article GET IT
Times cited: 97
FOXA1 is an independent prognostic marker for ER-positive breast cancer. Breast cancer research and treatment. 2011 Academic Article GET IT
Times cited: 99
High-level expression of forkhead-box protein A1 in metastatic prostate cancer. Histopathology. 2011 Academic Article GET IT
Times cited: 59
Personalized medicine: the road ahead. Clinical breast cancer. 2011 Review GET IT
Times cited: 40
Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22. Oncogene. 2010 Academic Article GET IT
Times cited: 110
Loss of ERα and FOXA1 expression in a progression model of luminal type breast cancer: insights from PyMT transgenic mouse model. Oncology reports. 2010 Academic Article GET IT
Times cited: 23
ITF2 is a target of CXCR4 in MDA-MB-231 breast cancer cells and is associated with reduced survival in estrogen receptor-negative breast cancer. Cancer biology & therapy. 2010 Academic Article GET IT
Times cited: 14
Expression of high-molecular-weight cytokeratin (34betaE12) is an independent predictor of disease-free survival in patients with triple-negative tumours of the breast. Journal of clinical pathology. 2010 Academic Article GET IT
Times cited: 9
Genomic and immunohistochemical analysis of adenosquamous carcinoma of the breast. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2010 Academic Article GET IT
Times cited: 50
Differential subcellular expression of protein kinase C betaII in breast cancer: correlation with breast cancer subtypes. Breast cancer research and treatment. 2010 Academic Article GET IT
Times cited: 16
Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment. Breast cancer research and treatment. 2009 Academic Article GET IT
Times cited: 156

more ...

less ...

Research

Sort by

Co-investigator Network

Funding awarded

2024 ROBERT A. WINN DIVERSITY IN CLINICAL TRIALS: CAREER DEVELOPMENT AWARD AGREEMENT Principal Investigator 2024 - 2027

more ...

less ...

Background

education and training

M.P.H., Indiana University School of Medicine 2010
M.B.,B.S., Topiwala Medical College, University of Bombay (India) 2007

Contact

full name

Rutika Mehta

primary email

rum9028@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Rutika Mehta Associate Professor of Medicine (Pending Appointment at Rank)

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

webpage

Phone

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

webpage